AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,083,018 | -10.6% | 2,750,829 | +2.3% | 0.34% | -13.7% |
| Q2 2023 | $76,147,637 | +58.4% | 2,688,829 | +28.5% | 0.40% | +48.5% |
| Q1 2023 | $48,072,282 | -15.5% | 2,092,829 | +3.3% | 0.27% | -21.8% |
| Q4 2022 | $56,885,278 | +34.4% | 2,025,829 | +35.3% | 0.34% | +45.3% |
| Q3 2022 | $42,330,000 | +43.2% | 1,496,829 | +12.3% | 0.23% | +45.3% |
| Q2 2022 | $29,553,000 | -23.8% | 1,333,012 | 0.0% | 0.16% | -13.9% |
| Q1 2022 | $38,804,000 | -6.1% | 1,333,012 | +6.1% | 0.19% | -9.2% |
| Q4 2021 | $41,304,000 | +9.3% | 1,256,578 | +53.5% | 0.21% | +17.0% |
| Q3 2021 | $37,786,000 | -40.9% | 818,767 | -29.4% | 0.18% | -32.6% |
| Q2 2021 | $63,928,000 | -1.0% | 1,160,000 | -7.2% | 0.26% | -18.7% |
| Q1 2021 | $64,550,000 | +49.0% | 1,250,000 | +25.0% | 0.32% | +23.0% |
| Q4 2020 | $43,330,000 | +14.3% | 1,000,000 | -7.7% | 0.26% | -0.4% |
| Q3 2020 | $37,920,000 | -43.3% | 1,083,429 | -13.3% | 0.26% | -51.0% |
| Q2 2020 | $66,850,000 | +50.7% | 1,250,000 | 0.0% | 0.54% | +40.4% |
| Q1 2020 | $44,350,000 | -25.7% | 1,250,000 | 0.0% | 0.38% | -5.5% |
| Q4 2019 | $59,688,000 | – | 1,250,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |